Our talented and purpose-driven team is dedicated to providing customers with life-transforming treatments for people living with serious neuropsychiatric conditions.
Chief Commercial Officer and General Manager
Lisa Mullett is Chief Commercial Officer of Sunovion Pharmaceuticals Inc. and General Manager of its subsidiary Sunovion Pharmaceuticals Canada Inc.
A member of the Executive Leadership Team, Ms. Mullett is responsible for guiding strategy and tactical plans for all marketed products and preparing for the commercialization of Sunovion’s future therapeutics. She oversees all sales, marketing, market access, commercial operations and customer service functions in the U.S. and Canada for the company’s product franchises. She also guides the organization’s overall business strategy in Canada and leads the cross-functional team responsible for driving the growth of products in the Canada market portfolio.
Ms. Mullett has over 25 years of pharmaceutical industry experience including senior leadership roles in Canadian, U.S. and global markets spanning sales and marketing, strategy and planning, government affairs, business development and new product planning across multiple therapeutic areas.
She joined the organization in 2008 and held roles of increasing responsibility including Director of Hospital Products, Director of Marketing and Director of the Central Nervous System (CNS) Business Unit in Canada.
From 2017 to 2019 at the Sunovion Pharmaceuticals Inc. corporate headquarters in the U.S., Ms. Mullett provided strategic expertise and guidance as Senior Director, Commercial Strategy & Planning, Chief of Staff to the Chief Commercial Officer and Executive Director, New Product Planning.
Ms. Mullett holds a Bachelor of Arts degree in Administrative and Commercial Studies from the University of Western Ontario.